Journal of Hematology & Thromboembolic Diseases
Open Access

David Jimenez

Biography

David Jiménez is Associate Professor of Medicine at the University of Alcalá de Henares, Madrid, Spain, and Chief of the Venous Thromboembolism Programme at the Ramón y Cajal Hospital in Madrid. He serves as a senior consulting physician at the Respiratory Department of Ramon y Cajal Hospital. He received his medical degree cum laude from the University of Alcalá de Henares.

Dr Jiménez’s interests include venous thromboembolism, pleural diseases and malignant mesothelioma, and clinical care, education and research for patients with pulmonary embolism (PE). He is currently President-Elect of the Vascular Sections of both the Spanish Society of Respiratory Medicine (SEPAR) and the Madrid Society of Respiratory Medicine (NEUMOMADRID).

Dr Jimenez has participated as Principal Investigator of several randomized clinical trials on thromboembolic prophylaxis and treatment. His research activity focuses on risk stratification and treatment of patients with PE. He is the Chairman of the PROTECT (prognostic value of CT scan for the prognosis of hemodynamically stable patients with PE) and the AINEP (diclofenaco for patients with submassive PE) studies, and a member of the Steering Committee of the PEITHO trial, which will assess the eficacy and safety of thrombolytics in intermediate-risk patients with PE.

He is also a member of several journal editorial boards, and is a peer reviewer for The Lancet, JAMA, the Journal of Thrombosis and Haemostasis, Thrombosis and Haemostasis, or Chest.

Research Interest

Venous thromboembolism; Pleural diseases; Malignant mesothelioma and Clinical care